Mode
Text Size
Log in / Sign up

Relaxation training and early benzodiazepines linked to respiratory recovery in adults with COPD, pneumonia, asthma, bronchiectasis, or interstitial lung diseaseCould early sedatives be slowing down lung recovery for adults with breathing problems?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that early benzodiazepine use within 72 hours is associated with reduced respiratory recovery odds in this observational cohort.

This retrospective observational study analyzed 389 consecutive adults (≥ 18 years) admitted with a primary diagnosis of chronic obstructive pulmonary disease, pneumonia, asthma, bronchiectasis, or interstitial lung disease at Hejiang County People’s Hospital in Sichuan Province, China. The exposure included relaxation training, sedative medication, or psychotropic medication use, compared to patients not receiving relaxation training. The primary outcome was respiratory recovery at discharge.

Independent factors associated with increased odds of respiratory recovery included younger age (OR = 0.96, 95% CI 0.94–0.98, P = 0.002), lower anxiety scores (OR = 0.87, 95% CI 0.81–0.93, P < 0.001), lower PaCO2 levels (OR = 0.94, 95% CI 0.91–0.97, P < 0.001), higher PaO2/FiO2 ratio (OR = 1.07 per 10-unit increase, 95% CI 1.03–1.12, P = 0.001), and lower CRP levels (OR = 0.98, 95% CI 0.97–0.99, P = 0.007). Participation in relaxation training was associated with increased odds of recovery (OR = 2.38, 95% CI 1.45–3.90, P < 0.001). Conversely, early benzodiazepine exposure within 72 hours of admission was associated with reduced likelihood of recovery (OR = 0.37, 95% CI 0.22–0.63, P < 0.001).

No specific adverse events, serious adverse events, discontinuations, or tolerability data were reported in the provided text. The study design is observational, meaning associations are reported rather than causation. Limitations regarding follow-up duration and specific safety outcomes were not reported. These findings suggest potential clinical relevance for managing anxiety and medication timing in respiratory care, though causality cannot be inferred.

Imagine being admitted to the hospital with a severe lung infection or chronic breathing trouble. You might feel anxious and restless, leading doctors to prescribe calming medications. But a new look at data from a hospital in Sichuan, China, suggests these early drugs might be working against your lungs. The team studied 389 adults who came in with conditions like asthma, bronchiectasis, or interstitial lung disease. They looked at whether getting these sedatives or psychotropic drugs early on helped or hurt their ability to recover.

The results were clear: taking benzodiazepines within 72 hours of admission was linked to a reduced likelihood of respiratory recovery. In plain terms, those who received these drugs early were less likely to see their breathing improve before discharge compared to those who did not. This association held true even when accounting for other factors like age and how anxious a patient felt. Interestingly, lower anxiety scores were also linked to better recovery, suggesting that managing stress without heavy sedation might be beneficial.

Other signs of lung health, such as oxygen levels and inflammation markers, also predicted recovery. However, the study cannot prove that the drugs caused the slower recovery, only that they are linked to it. This is an observational study, meaning it tracks what happens naturally without assigning treatments. While the findings are important, they do not mean every patient needs to avoid these life-saving drugs if they are truly necessary for safety. The key takeaway is that doctors should carefully weigh the benefits of calming a patient against the potential impact on lung healing.

What this means for you:
Early use of sedatives within 72 hours was linked to lower odds of breathing recovery in hospitalized lung patients.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundPsychological distress and sedative medication exposure are common among hospitalized patients with respiratory diseases and may influence clinical recovery. However, evidence regarding the combined impact of relaxation training and medication use on respiratory outcomes remains limited. This study aimed to examine the association between relaxation training, sedative or psychotropic medication use, and respiratory recovery in patients hospitalized with respiratory diseases.MethodsA retrospective observational study was conducted using electronic medical records from Hejiang County People’s Hospital, Sichuan Province, China. Consecutive adults ( ≥ 18 years) admitted with a primary diagnosis of chronic obstructive pulmonary disease, pneumonia, asthma, bronchiectasis, or interstitial lung disease between January 2020 and January 2025 were included. Patients were categorized according to documented exposure to relaxation training during hospitalization. The primary outcome was respiratory recovery at discharge, defined a priori using objective criteria based on routinely documented records: successful discontinuation of invasive or non-invasive ventilatory support (if applicable), oxygen saturation ≥ 95% on room air for ≥ 4 h, respiratory rate 12–24 breaths/min at rest, and no evidence of ongoing respiratory failure (pH ≥ 7.35 and no worsening hypercapnia [PaCO2 not increasing compared with the most recent prior measurement] and/or PaO2 ≥ 60 mmHg on room air when an arterial blood gas test was available within 24 h before discharge). Variables associated with recovery were identified using univariate and multivariable logistic regression analyses. Model discrimination, calibration, and clinical utility were assessed by the concordance index (C-index), Hosmer–Lemeshow test, calibration plot, and decision curve analysis.ResultsA total of 389 patients were included (mean age 63.3 ± 12.2 years; 58.1% male), of whom 158 (40.6%) received relaxation training. In multivariable analysis, younger age (OR = 0.96, 95% CI 0.94–0.98, P = 0.002), lower anxiety scores (OR = 0.87, 95% CI 0.81–0.93, P < 0.001), lower PaCO2 levels (OR = 0.94, 95% CI 0.91–0.97, P < 0.001), higher PaO2/FiO2 ratio (OR = 1.07 per 10-unit increase, 95% CI 1.03–1.12, P = 0.001), and lower CRP levels (OR = 0.98, 95% CI 0.97–0.99, P = 0.007) were independently associated with respiratory recovery. Participation in relaxation training significantly increased the odds of recovery (OR = 2.38, 95% CI 1.45–3.90, P < 0.001), whereas early benzodiazepine exposure within 72 h of admission reduced the likelihood of recovery (OR = 0.37, 95% CI 0.22–0.63, P < 0.001). The predictive model demonstrated good discrimination (C-index = 0.872, 95% CI 0.799–0.944) and satisfactory calibration (Hosmer–Lemeshow χ2 = 6.585, P = 0.582). Decision curve analysis indicated a higher net clinical benefit of the model across relevant probability thresholds.ConclusionIn this retrospective cohort of hospitalized patients with respiratory diseases, engagement in relaxation training was independently associated with improved respiratory recovery, whereas early sedative medication exposure predicted poorer outcomes. Psychological and physiological parameters jointly influenced recovery probability. These findings underscore the importance of integrating psychological relaxation interventions and cautious sedative management in the clinical care of respiratory patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.